The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; none of the 6 sources its claims cite is checked for support yet.
SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Open accessAbstract
The Sir2 deacetylase regulates chromatin silencing and lifespan in Saccharomyces cerevisiae. In mice, deficiency for the Sir2 family member SIRT6 leads to a shortened lifespan and a premature ageing-like phenotype. However, the molecular mechanisms of SIRT6 function are unclear. SIRT6 is a chromatin-associated protein, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown. Here we show that the human SIRT6 protein is an NAD+-dependent, histone H3 lysine 9 (H3K9) deacetylase that modulates telomeric chromatin. SIRT6 associates specifically with telomeres, and SIRT6 depletion leads to telomere dysfunction with end-to-end chromosomal fusions and premature cellular senescence. Moreover, SIRT6-depleted cells exhibit abnormal telomere structures that resemble defects observed in Werner syndrome, a premature ageing disorder. At telomeric chromatin, SIRT6 deacetylates H3K9 and is required for the stable association of WRN, the factor that is mutated in Werner syndrome. We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function. Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Human SIRT6 is an NAD+-dependent histone H3 lysine 9 (H3K9) deacetylase that associates with telomeres in S phase and maintains low H3K9 acetylation there. SIRT6 depletion causes telomere dysfunction, chromosomal end-to-end fusions, and premature cellular senescence, and impairs WRN association at telomeric chromatin, linking SIRT6 to telomere maintenance and Werner syndrome-like defects.
Key findings
- SIRT6 knockdown in WI-38 human fibroblasts shortened replicative lifespan, causing premature senescence about ten population doublings before controls, with increased senescence-associated β-galactosidase staining; two independent SIRT6 shRNAs reproduced this, while irrelevant shRNAs did not.
- SIRT6-depleted cells showed elevated telomere dysfunction-induced foci, non-recurrent chromosomal end-to-end fusions that were more pronounced at later population doublings, and Werner syndrome-like telomere abnormalities including sister telomere loss, telomere doublets, and weak or absent telomere signals at fusion sites; mean telomere length was not significantly reduced.
- SIRT6 deacetylated H3K9Ac specifically among tested acetylated histone peptides, with no deacetylation detected for 12 other acetylated histone peptides; the catalytic mutant H133Y markedly decreased activity. SIRT6 knockdown caused H3K9 hyperacetylation at telomeric chromatin in S phase, and S6KO mouse cells also showed telomeric H3K9 hyperacetylation.
- SIRT6 was required for stable WRN association at telomeric chromatin; SIRT6 knockdown significantly inhibited WRN association in U2OS and IMR90 cells. Telomerase expression reversed premature senescence, whereas augmenting base excision repair did not, and low oxygen culture did not prevent senescence.
Methods
- Retrovirus-mediated shRNA knockdown of SIRT6 in WI-38, IMR90, U2OS, and HeLa cells, with replicative senescence assays, SA-β-gal staining, immuno-FISH TIF assays, metaphase cytogenetics/SKY/telomere FISH, and cell-cycle flow cytometry.
- Telomere chromatin immunoprecipitation (T-ChIP) after thymidine synchronization and release, using antibodies against SIRT6, Flag, WRN, and H3K9Ac, with telomeric DNA detected by slot blot.
- In vitro histone deacetylation assays with recombinant SIRT6 and acetylated histone tail peptides or full-length histones, including mass spectrometry; 293T cells were transfected with wild-type or H133Y SIRT6 and analyzed by Western blotting.
Limitations
- Stated: SIRT6 showed only modest in vitro deacetylation activity on H3K9Ac peptides, and no direct SIRT6-WRN interaction at chromatin was observed, although additional functional or physical interactions might exist.
- Stated: S6KO mouse cells showed telomeric H3K9 hyperacetylation but did not display the downstream cellular defects seen in human cells, which the authors attribute to the large functional reserve of mouse telomeres.
- Evident: many conclusions rely on shRNA knockdown and overexpression in cultured cells, and several supporting results are reported as “data not shown”; global H3K9Ac levels did not differ significantly, so the key effect is telomere-specific.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
29 Own result · 23 Own interpretation · 3 Not checked yet · 1 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As controls, the association of Alu repeat sequences with SIRT6 ChIPs was not above background (Fig. 2b–d), and the SIRT6 T-ChIP signal was abolished in S6KD cells, validating the specificity of the signal (Fig. 2d).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In both U2OS and IMR90 cells, SIRT6 knockdown significantly inhibited the association of WRN with telomeric chromatin (Fig. 4a, b, and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, mean telomere length was not significantly reduced in S6KD cells (Supplementary Fig. 5).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Inactivation of SIRT6 leads to H3K9 hyperacetylation at telomeric chromatin in both human and mouse cells, but the mouse cells do not display the downstream cellular defects observed in human cells, which is consistent with the large functional reserve of mouse telomeres (Supplementary Fig. 13d; data not shown)14,25.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, telomere stabilization (by the ectopic expression of telomerase (hTERT)) reversed the premature senescence of S6KD, whereas augmenting BER (by the ectopic expression of the DNA polymerase-β dRP lyase domain) did not (Fig. 1g and Supplementary Fig. 6).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of TIFs revealed elevated telomere dysfunction in S6KD cells (Fig. 1d, e, and Supplementary Fig. 4a).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, SIRT6 knockdown in U2OS cells resulted in delayed completion of S phase (Supplementary Fig. 14), which is consistent with a role for SIRT6 in modulating telomeres during replication.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, investigation of histone acetylation status at telomeres in S-phase-enriched cultures by T-ChIP revealed H3K9 hyperacetylation in S6KD cells (Fig. 3d–f).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 18
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Premature cellular senescence was also observed with two independent SIRT6 shRNAs, ruling out off-target shRNA effects, but not with irrelevant shRNAs (Supplementary Fig 2b–d and Supplementary Fig 3c).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 occupancy at telomeric chromatin was observed for both recombinant Flag-tagged SIRT6 (Fig. 2a, b) and endogenous SIRT6 (Fig. 2c, d), and in both U2OS osteosarcoma cells (Fig. 2b, c) and primary IMR90 cells (Fig. 2d).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This activity was highly specific for H3K9Ac, because no deacetylation was detected for 12 other acetylated histone peptides (Fig. 3a and Supplementary Fig. 11).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 also deacetylated H3K9Ac, but not several other acetylated residues, in the context of purified full-length histone H3, and mutation of a conserved catalytic residue (H133Y) of SIRT6 markedly decreased this activity (Fig. 3b and data not shown).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SIRT6 knockdown (S6KD) cells have a strikingly shortened replicative lifespan, undergoing premature cellular senescence about ten population doublings before control cells, and show increased levels of senescence-associated β-galactosidase (SA-β-gal) staining (Fig. 1b, c, and Supplementary Fig. 2a).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, SIRT6 efficiently and specifically deacetylated H3K9Ac (but not other acetylated histone residues) in 293T cells, whereas the mutant SIRT6 protein did not (Fig. 3c and Supplementary Fig. 12).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Non-recurrent chromosomal end-to-end fusions were observed in S6KD cells and were more pronounced at later population doublings, but they were rarely observed in control cells (Fig. 1f and Supplementary Fig. 4b, c).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“First, S6KD metaphases showed elevated levels of missing telomere signals (sister telomere loss) and extra telomere signals (telomere doublets) (Fig. 4d–f), defects observed in WS cells and associated with aberrant telomere processing during replication8,13,20.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations suggest that S6KD cells undergo accelerated senescence and telomere dysfunction in response to stochastic telomere sequence loss, without increased global telomere erosion.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We conclude that SIRT6 is crucial in maintaining a normal replicative life-span and in preventing the premature senescence of human cells.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these data locate SIRT6 at telomeric chromatin in S phase and suggest a potential role for SIRT6 in regulating replication-associated dynamics in telomere structure.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings suggest that SIRT6 collaborates with WRN at telomeric chromatin to ensure efficient telomere replication and to prevent the accrual of structural abnormalities at telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study has identified a crucial function for SIRT6 in chromatin regulation at mammalian telomeres and provides a new mechanism by which the regulation of chromatin is linked to telomere function, cellular senescence and, potentially, organismal ageing.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations indicate that SIRT6 is an NAD-dependent deacetylase with specificity for H3K9Ac.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose a model (Supplementary Fig. 1) in which the deacetylation of H3K9Ac by SIRT6 promotes the formation of a specialized telomeric chromatin state that is required for the stable association of S-phase-dependent telomere-processing factors such as WRN, to prevent aberrant sequence loss or metabolism of telomeres.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these findings demonstrate that telomere dysfunction, not BER defects or oxidative stress, underlie the premature senescence phenotype of S6KD cells.”
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
No enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.
“SIRT6 is a chromatin-associated protein3, but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown.”
“Although no physiological enzymatic activity for SIRT6 on histones or other trans substrate has yet been observed, we proposed that SIRT6 might regulate chromatin at telomeres by deacetylating a specific histone tail residue.”
The paper relies on this without support.
No effect of SIRT6 deficiency on cellular lifespan has been reported.
“Despite the ageing-like phenotype of SIRT6-deficient mice, no effect of SIRT6 deficiency on cellular lifespan has been reported.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SIRT6 promotes DNA double strand break repair19,20, regulates telomere stability21, suppresses inflammation22 and opposes tumorigenesis23,24.”
From SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age (2014) · cites this paper as [21]
In the citing paper
“In human cells, loss of SIRT6, an H3K9 deacetylase that silences telomeres, causes telomere dysfunction and premature cellular senescence (Michishita et al., 2008).”
From The Aging Epigenome (2016) · cites this paper as Michishita et al., 2008
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar‐Am, I., Soenksen, D. G., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,753
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6
Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M. M., et al. (2006) · Cell · doi:10.1016/j.cell.2005.11.044 · Cited by 1,637
Self-citationDNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
Self-citationHerbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
Cited by
Sorted by citations
Items 501–600 of 998
Fabp4-Cre-mediated Sirt6 deletion impairs adipose tissue function and metabolic homeostasis in mice
Xiong, X., Zhang, C., Zhang, Y., Fan, R., Qian, X., & Dong, X. C. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0033 · Cited by 45
Diani-Moore, S., Shoots, J., Singh, R., Zuk, J. B., & Rifkind, A. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-02332-9 · Cited by 42
Li, N., Mao, D., Cao, Y., Li, H., Ren, F., & Li, K. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4304 · Cited by 42
MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.
Shi, S., Yang, Y., Liu, M., Liu, B., Yang, X. P., Yu, M., Qi, H., Ren, M., Wang, Z., Zou, J., et al. (2018) · Europe PMC (PubMed Central) · Cited by 42
Mao, Q., Gong, X., Zhou, C., Tu, Z., Zhao, L., Wang, L., Wang, X., Sun, L., Xia, J., Lian, B., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.035 · Cited by 43
Major depressive disorder mediates accelerated aging in rats subjected to chronic mild stress
Xie, X., Chen, Y., Ma, L., Shen, Q., Huang, L., Zhao, B., Wu, T., & Fu, Z. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.022 · Cited by 44
Emerging Roles of Sirtuins in Ischemic Stroke
She, D. T., Jo, D., & Arumugam, T. V. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0544-4 · Cited by 41
Mitochondrial regulation of cardiac aging
Wang, Y., Li, Y., He, C., Gou, B., & Song, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.008 · Cited by 44
Genome-Protecting Compounds as Potential Geroprotectors
Proshkina, E., Shaposhnikov, M. V., & Moskalev, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124484 · Cited by 42
Chen, X., Sun, W., Huang, S., Zhang, H., Lin, G., Li, H., Qiao, J., Li, L., & Yang, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01183 · Cited by 40
SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation
Zhao, G., Wang, H., Xu, C., Wang, P., Chen, J., Wang, P., Sun, Z., Su, Y., Wang, Z., Han, L., et al. (2016) · Aging · doi:10.18632/aging.101038 · Cited by 41
Sirt6 Promotes DNA End Joining in iPSCs Derived from Old Mice
Chen, W., Liu, N., Zhang, H., Zhang, H., Qiao, J., Jia, W., Zhu, S., Mao, Z., & Kang, J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.082 · Cited by 42
Arsiwala, T., Pahla, J., van Tits, L. J., Bisceglie, L., Gaul, D. S., Costantino, S., Miranda, M. X., Nussbaum, K., Stivala, S., Błyszczuk, P., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.01.002 · Cited by 40
Fueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity
Ruszkiewicz, J. A., Bürkle, A., & Mangerich, A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102037 · Cited by 42
The role of mammalian sirtuins in cancer metabolism
Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 39
Mechanisms of Stress‐Induced Visceral Pain: Implications in Irritable Bowel Syndrome
Meerveld, B. G., Moloney, R. D., Johnson, A. C., & Vicario, M. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12361 · Cited by 39
SIRT7 functions in redox homeostasis and cytoskeletal organization during oocyte maturation
Gao, M., Li, X., He, Y., Han, L., Qiu, D., Li, L., Liu, H., Liu, J., & Gu, L. (2018) · The FASEB Journal · doi:10.1096/fj.201800078rr · Cited by 39
Histone Modifications and the Maintenance of Telomere Integrity
Jezek, M., & Green, E. M. (2019) · Cells · doi:10.3390/cells8020199 · Cited by 41
SIRT6 participates in the quality control of aged oocytes via modulating telomere function
Ge, J., Li, C., Li, C., Huang, Z., Zeng, J., Han, L., & Wang, Q. (2019) · Aging · doi:10.18632/aging.101885 · Cited by 42
Sirtuin Modulators in Cellular and Animal Models of Human Diseases
Hong, J. Y., & Lin, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735044 · Cited by 40
Sirtuins at the Breaking Point: SIRT6 in DNA Repair
Lombard, D. B. (2008) · Aging · doi:10.18632/aging.100014 · Cited by 40
Role of Sirtuins in Stem Cell Differentiation
Rodríguez, R. M. A., Fernández, A. F., & Fraga, M. F. (2013) · Genes & Cancer · doi:10.1177/1947601913479798 · Cited by 39
Functional Analysis of Sirtuin Genes in Multiple Plasmodium falciparum Strains
Merrick, C. J., Jiang, R. H. Y., Skillman, K. M., Samarakoon, U., Moore, R. M., Dzikowski, R., Ferdig, M. T., & Duraisingh, M. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118865 · Cited by 38
Synthetic Chromatin Acylation by an Artificial Catalyst System
Ishiguro, T., Amamoto, Y., Tanabe, K., Liu, J., Kajino, H., Fujimura, A., Aoi, Y., Osakabe, A., Horikoshi, N., Kurumizaka, H., et al. (2017) · Chem · doi:10.1016/j.chempr.2017.04.002 · Cited by 38
The Growing Landscape of Succinylation Links Metabolism and Heart Disease
Yang, L., Miao, S., Zhang, J., Wang, P., Liu, G., & Wang, J. (2021) · Epigenomics · doi:10.2217/epi-2020-0273 · Cited by 39
Vitamin B3, the nicotinamide adenine dinucleotides and aging
Xu, P., & Sauve, A. A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.03.006 · Cited by 38
Putative tumor suppression function of SIRT6 in endometrial cancer
Fukuda, T., Wada‐Hiraike, O., Oda, K., Tanikawa, M., Makii, C., Inaba, K., Miyasaka, A., Miyamoto, Y., Yano, T., Maeda, D., et al. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.06.043 · Cited by 37
Lysine Fatty Acylation: Regulatory Enzymes, Research Tools, and Biological Function
Komaniecki, G., & Lin, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.717503 · Cited by 37
Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors
Kokkonen, P., Rahnasto‐Rilla, M., Kiviranta, P. H., Huhtiniemi, T., Laitinen, T., Poso, A., Jarho, E. M., & Lahtela-Kakkonen, M. K. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300139n · Cited by 37
Epigenetic regulation by quercetin: a comprehensive review focused on its biological mechanisms
Zhu, J., Cheng, X., Naumovski, N., Hu, L. T., & Wang, K. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2278760 · Cited by 38
Kim, K. S., Park, H., Lee, J. W., Kim, Y. I., & Shin, M. K. (2015) · Microscopy Research and Technique · doi:10.1002/jemt.22472 · Cited by 36
Emerging Roles of Sirtuin 6 in Alzheimer’s Disease
Nasir, N. F. M., Zainuddin, A., & Shamsuddin, S. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-1005-y · Cited by 36
Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
Ghosh, S., Wong, S. K. K., Jiang, Z., Liu, B., Wang, Y., Hao, Q., Gorbunova, V. A., Liu, X., & Zhou, Z. (2018) · eLife · doi:10.7554/elife.32127 · Cited by 37
Jia, Q., Cui, C., Deng, Q., Wang, L., Chen, R., Zhai, D., Xie, L., & Yu, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9400 · Cited by 37
Mechanism of activation for the sirtuin 6 protein deacylase
Klein, M. A., Liu, C., Kuznetsov, V. I., Feltenberger, J. B., Tang, W., & Denu, J. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011285 · Cited by 37
Albert, E., & Laimins, L. A. (2020) · Viruses · doi:10.3390/v12070744 · Cited by 41
The SIRT6-Autophagy-Warburg Effect Axis in Papillary Thyroid Cancer
Zhou, Y., Huang, R., Wei, X., Yu, W., Min, Z., & Ye, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01265 · Cited by 37
Sirtuins, aging, and cardiovascular risks
Favero, G., Franceschetti, L., Rodella, L. F., & Rezzani, R. (2015) · AGE · doi:10.1007/s11357-015-9804-y · Cited by 36
PARP is involved in replicative aging in Neurospora crassa
Kothe, G. O., Kitamura, M., Masutani, M., Selker, E. U., & Inoue, H. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.12.012 · Cited by 38
Sirtuin 6, a possible therapeutic target for type 2 diabetes
Bae, E. J. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0989-8 · Cited by 36
Huang, Y., Zhang, J., Xu, D., Yu, P., Jin, Y., & Zhang, L. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12006 · Cited by 35
Kok, S., Hou, K., Hong, C., Chao, L., Lai, E. H., Wang, H.-W., Yang, H., Shun, C., Wang, J., & Lin, S. (2015) · Journal of Endodontics · doi:10.1016/j.joen.2015.05.008 · Cited by 35
SIRT6 polymorphism rs117385980 is associated with longevity and healthy aging in Finnish men
Hirvonen, K., Laivuori, H. M., Lahti, J. M. T., Strandberg, T. E., Eriksson, J. G., & Hackman, P. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0401-z · Cited by 33
SIRT6 promotes osteogenic differentiation of mesenchymal stem cells through BMP signaling
Zhang, P., Liu, Y., Wang, Y., Zhang, M., Lv, L., Zhang, X., & Zhou, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-10323-z · Cited by 35
Vadla, R., & Haldar, D. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1404207 · Cited by 34
Activation and inhibition of sirtuins: From bench to bedside
Fiorentino, F., Fabbrizi, E., Mai, A., & Rotili, D. (2024) · Medicinal Research Reviews · doi:10.1002/med.22076 · Cited by 35
Sirtuin 6 is a histone delactylase
Nickel, G. A., Pederson, N. J., Faheem, F., Yang, Z., Bulf, J., & Diehl, K. L. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110795 · Cited by 37
When Sirtuins and NF-κB Collide
Natoli, G. (2009) · Cell · doi:10.1016/j.cell.2008.12.034 · Cited by 33
Lee, W. K., & Cho, M. H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw067 · Cited by 33
Role of Sirtuins in Maintenance of Genomic Stability: Relevance to Cancer and Healthy Aging
Wu, X., Neng, C., Fenech, M. F., & Wang, X. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3280 · Cited by 33
The inflammatory effect of epigenetic factors and modifications in type 2 diabetes
Akbari, M., & Hassan‐Zadeh, V. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00663-9 · Cited by 33
Sirtuin Deacetylases as Therapeutic Targets in the Nervous System
Langley, B. C., & Sauve, A. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0214-5 · Cited by 33
Epigenetics: Linking Nutrition to Molecular Mechanisms in Aging.
Park, J. H., Yoo, Y., & Park, Y. J. (2017) · PubMed Central · doi:10.3746/pnf.2017.22.2.81 · Cited by 34
SIRT3/6: an amazing challenge and opportunity in the fight against fibrosis and aging
Wei, W., Li, T. X., Chen, J., Fan, Z., Gao, F., Yu, Z., & Jiang, Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05093-z · Cited by 34
Diani-Moore, S., Zhang, S., Ram, P., & Rifkind, A. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458067 · Cited by 34
Itoh, E., Odakura, R., Oinuma, K.-I., Shimizu, M., Masuo, S., & Takaya, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753772 · Cited by 32
Sirtuins and Accelerated Aging in Scleroderma
Wyman, A. E., & Atamas, S. P. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0724-6 · Cited by 32
Assadi‐Porter, F. M., Reiland, H., Sabatini, M., Lorenzini, L., Carnicelli, V., Rogowski, M. P., Alpergin, E. S. S., Tonelli, M., Ghelardoni, S., Saba, A., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051535 · Cited by 32
Hong, J., Mei, C., Raza, S. H. A., Khan, R., Cheng, G., & Zan, L. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108260 · Cited by 32
SETD6 is a negative regulator of oxidative stress response
Chen, A., Feldman, M., Vershinin, Z., & Levy, D. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.01.003 · Cited by 30
Cardinale, A., de Stefano, M. C., Mollinari, C., Racaniello, M., Garaci, E., & Merlo, D. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1465-1 · Cited by 32
Lin, H., Hao, Y., Zhao, Z., & Tong, Y. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12265 · Cited by 32
RetractedEpigenetic Regulation in Kidney Toxicity: Insights From Cisplatin Nephrotoxicity
Xiang, X., Guo, C., Tang, C., Cai, J., & Dong, Z. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.12.005 · Cited by 31
Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
Ke, X., Lin, Z.-R., Ye, Z., Leng, M., Chen, B., Jiang, C., Jiang, X., & Li, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.679655 · Cited by 33
Sirtuins in Hematological Aging and Malignancy
Roth, M., Wang, Z., & Chen, W. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013010187 · Cited by 31
SIRTain regulators of premature senescence and accelerated aging
Ghosh, S., & Zhou, Z. (2015) · Protein & Cell · doi:10.1007/s13238-015-0149-1 · Cited by 31
Raj, S., Dsouza, L. A., Singh, S. P., & Kanwal, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598326 · Cited by 31
Grimley, R. L., Polyakova, O., Vamathevan, J. J., McKenary, J., Hayes, B. J., Patel, C. B., Smith, J. L., Bridges, A. M., Fosberry, A. P., Bhardwaja, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039847 · Cited by 30
Liu, F., Bu, H., Geng, H., Plaen, I. G. D., Gao, C., Wang, P., Wang, X. Q., Kurowski, J. A., Yang, H. B., Qian, J., et al. (2017) · Molecular Medicine · doi:10.2119/molmed.2017.00085 · Cited by 31
Overexpression of Sirt6 is a novel biomarker of malignant human colon carcinoma
Geng, C., Zhang, C., Zhang, J., Gao, P. H., He, M., & Li, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26539 · Cited by 31
Chow, T. T., Shi, X., Wei, J., Guan, J., Stadler, G., Huang, B., & Blackburn, E. H. (2018) · Nature Communications · doi:10.1038/s41467-018-05840-y · Cited by 32
Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD
Yang, Z., Yu, Y., Sun, N., Zhou, L., Zhang, D., Chen, H., Miao, W., Gao, W., Zhang, C. Y., Liu, C., et al. (2020) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.07.005 · Cited by 30
Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities
Rahnasto‐Rilla, M., Järvenpää, J. P., Huovinen, M., Schroderus, A., Ihantola, E., Küblbeck, J., Khadeer, M., Moaddel, R., & Lahtela-Kakkonen, M. K. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110701 · Cited by 30
Connexins in Cancer: Jekyll or Hyde?
Mulkearns-Hubert, E. E., Reizes, O., & Lathia, J. D. (2020) · Biomolecules · doi:10.3390/biom10121654 · Cited by 29
Effects of SIRT6 silencing on collagen metabolism in human dermal fibroblasts
Baohua, Y., & Li, L. (2011) · Cell Biology International · doi:10.1042/cbi20110268 · Cited by 30
Telomeres and disease: Enter TERRA
Maicher, A., Kastner, L., & Luke, B. (2012) · RNA Biology · doi:10.4161/rna.20330 · Cited by 30
Epigenetic biomarkers in aging and longevity: Current and future application
Izadi, M., Sadri, N., Abdi, A., Serajian, S., Jalalei, D., & Tahmasebi, S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122842 · Cited by 32
Ghosh, L. D., Jain, A., Sundaresan, N. R., & Chatterjee, K. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.03.012 · Cited by 29
The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link
Amsalem, Z., Arif, T., Shteinfer‐Kuzmine, A., Caspi, V. C., & Shoshan‐Barmatz, V. (2020) · Cancers · doi:10.3390/cancers12041031 · Cited by 30
MicroRNA and Senescence: The Senectome, Integration and Distributed Control
Bilsland, A. E., Revie, J., & Keith, W. N. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007197 · Cited by 30
Sirtuin biology and relevance to diabetes treatment
Dong, X. C. (2012) · Diabetes Management · doi:10.2217/dmt.12.16 · Cited by 29
Kawaguchi, M., Ikegawa, S., Ieda, N., & Nakagawa, H. (2016) · ChemBioChem · doi:10.1002/cbic.201600374 · Cited by 28
Kim, J. H., Lee, J. M., Kim, J., & Kim, K. R. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.057 · Cited by 28
Targeting Cancer through the Epigenetic Features of Telomeric Regions
Vaquero-Sedas, M. I., & Vega-Palas, M. A. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.006 · Cited by 28
Mitra, N., & Dey, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108226 · Cited by 28
The epigenetic regulation of centromeres and telomeres in plants and animals
Achrem, M., Szućko-Kociuba, I., & Kalinka, A. (2020) · Comparative Cytogenetics · doi:10.3897/compcytogen.v14i2.51895 · Cited by 29
Liu, X., Yang, Z., Li, H., Luo, W., Duan, W., Zhang, J., Zhu, Z., Liu, M., Li, S., Xin, X., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7374086 · Cited by 28
Pradhan, R., Singh, A. K., Kumar, P., Bajpai, S., Pathak, M., Chatterjee, P., Dwivedi, S. N., Dey, A. B., & Dey, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02671-9 · Cited by 28
MicroRNAs in heart failure: Non-coding regulators of metabolic function
Zhang, X., & Schulze, P. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.009 · Cited by 28
Cosmeceutical product consisting of biomimetic peptides: antiaging effects in vivo and in vitro
Gazitaeva, Z., Дробинцева, А. О., ., Y. C., Polyakova, V., & Kvetnoy, I. M. (2017) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s97573 · Cited by 30
NAD metabolism in aging and cancer
Kincaid, J. W. R., & Berger, N. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220929287 · Cited by 29
Sirtuin mechanism and inhibition: explored with Nε-acetyl-lysine analogs
Hirsch, B. M., & Zheng, W. (2010) · Molecular BioSystems · doi:10.1039/c0mb00033g · Cited by 27
Cooperation of DNA-PKcs and WRN helicase in the maintenance of telomeric D-loops
Kusumoto‐Matsuo, R., Opresko, P. L., Ramsden, D. A., Tahara, H., & Bohr, V. A. (2010) · Aging · doi:10.18632/aging.100141 · Cited by 28
Self-citationSirt6 deacetylase activity regulates circadian rhythms via Per2
Sun, S., Liu, Z., Feng, Y., Shi, L., Cao, X., Cai, Y., & Liu, B. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.143 · Cited by 27
Sirtuins and SIRT6 in Carcinogenesis and in Diet
Teixeira, M. C., Sánchez‐López, E., Espina, M., García, M. L., Durazzo, A., Lucarini, M., Novellino, E., Souto, S. B., Santini, A., & Souto, E. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194945 · Cited by 27
Sirtuin Oxidative Post-translational Modifications
Kalous, K., Wynia‐Smith, S. L., & Smith, B. C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.763417 · Cited by 28
Sirt6 mediates antioxidative functions by increasing Nrf2 abundance
Liu, X., Ren, S., Li, Z., Hao, D., Zhao, X., Zhang, Z., & Liu, D. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113409 · Cited by 27
Cyclic peptide-based potent human SIRT6 inhibitors
Liu, J., & Zheng, W. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob02339d · Cited by 27
Yeast Sirtuin Family Members Maintain Transcription Homeostasis to Ensure Genome Stability
Feldman, J. L., & Peterson, C. L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.009 · Cited by 26
Sirtuins in female meiosis and in reproductive longevity
Vázquez, B. N., Vaquero, A., & Schindler, K. (2020) · Molecular Reproduction and Development · doi:10.1002/mrd.23437 · Cited by 26
Metadata
- Authors
- Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L. A., Barrett, J. C., Chang, H. Y., Bohr, V. A., Ried, T., Gozani, O., & Chua, K. F.
- Affiliations
- Stanford Medicine (US)
- VA Palo Alto Health Care System (US)
- Department of Biological Sciences (RU)
- National Institutes of Health (US)
- Corresponding author
- Chua, Katrin F.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7186
- Pages
- 492-496
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2646112
- OpenAlex
- W2029969982
- Semantic Scholar
- e93e298451cb0d965e8933da9a3ab04e44f65ff0
- Cited by
- 1,111
- References
- 32
- Citations by year
- 2026: 35 · 2025: 35 · 2024: 45 · 2023: 59 · 2022: 57 · 2021: 68 · 2020: 75 · 2019: 64 · 2018: 75 · 2017: 63 · 2016: 83 · 2015: 68 · 2014: 62 · 2013: 94 · 2012: 57
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (R01AG028867, K08AG028961)
- National Institute of General Medical Sciences (R01GM079641)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- SIRT6, telomeric chromatin, telomere maintenance, premature aging, Werner syndrome, WRN, cellular senescence, chromatin silencing, telomere dysfunction, NAD+-dependent deacetylation
- MeSH terms
- Werner Syndrome Helicase, Acetylation, Cell Line, Chromatin, DNA Replication, Exodeoxyribonucleases, Fibroblasts, Histone Deacetylases, Histones, Humans, Lysine, Phenotype, Protein Binding, Werner Syndrome, Telomere, Cellular Senescence, Telomerase, Sirtuins, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
